If a physician gives a "sample" prescription drug to a patient during an office visit but does not yet write an actual prescription for it, would that count toward prescription drug management on the Levels of Medical Decision Making (MDM) table in the CPT 2025 code set? ...
Subscribe or sign in to view the full article.
Article Overview
This short coding guidance article addresses how a physician or other qualified health care professional may consider a sample prescription drug in the context of CPT 2025 medical decision making. It is relevant to professional coders, auditors, and clinicians who document office visit complexity and medication-related risk elements.
Why This Topic Matters
Understanding how sample medications fit into medical decision making helps support consistent documentation and evaluation of office visit complexity in CPT-based reporting.
What You Will Learn
- How the article frames prescription drug management in relation to office visit documentation
- Which documentation context is relevant when a sample medication is provided
- How the guidance ties medication-related risk assessment to CPT 2025 medical decision making
- What type of provider context the article discusses
Who Should Read This
- Medical coders
- Coding auditors
- Physicians
- Other qualified health care professionals
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com